The Oxytocin Neurons in the Paraventricular Nucleus Are Essential for Chronic Sleep Deprivation‐Mediated Anxiety‐Related Behaviors

Yuxin Wang, Yifei Zhang, Yanchao Liu, Zhendong Xu, Jiyan Zhang, Like Wang, Yufeng Cang, Xin Jin, Fuyu Han, Zhouhua Li, Chuanwei Hu, Xiangjie Kong, Yuchen Deng, Lu Zhang, Hairong Wang, Haibo Xu, Ming Chen, Linlin BiCNS 2025 · DOI

TL;DR

This study reveals that chronic sleep deprivation (CSD) impairs oxytocin neurons in the paraventricular nucleus (PVN), leading to anxiety. The researchers demonstrate that stimulating these neurons can reverse CSD-induced anxiety by modulating synaptic plasticity and oxytocin release in the medial prefrontal cortex (mPFC).

What Problem Does This Paper Address?

Sleep disturbances are strongly linked to anxiety disorders, yet the underlying neural mechanisms remain poorly understood. Specifically, how chronic sleep deprivation (CSD) impacts brain circuits that regulate emotional states, and whether these circuits can be therapeutically targeted, is an open question. This paper investigates the role of oxytocin neurons in the paraventricular nucleus (PVN), a key brain region involved in stress and anxiety, in mediating anxiety-like behaviors induced by CSD.

Methods

The researchers employed a multi-faceted approach combining optogenetics, electrophysiology, and behavioral assays in mice.

  • Optogenetics: They used viral vectors (AAV2/9) to express channelrhodopsin (ChR2) or halorhodopsin (eNpHR3.0) in PVN oxytocin (PVNOXT) neurons. This allowed them to precisely control the activity of these neurons using light stimulation. Different stimulation patterns were tested:
  • Instant optogenetic activation: Used to assess immediate effects on anxiety.
  • Long-term low-frequency (LTF) stimulation: Explored prolonged inhibition.
  • Short-term high-frequency (HFS) stimulation: Investigated its potential to reverse CSD effects.
  • Electrophysiology: Whole-cell patch-clamp recordings were performed on PVNOXT neurons to measure excitatory postsynaptic currents (EPSCs) and inhibitory postsynaptic currents (IPSCs). This helped to understand how CSD and optogenetic stimulation affected neuronal excitability and synaptic transmission, specifically focusing on AMPA and NMDA receptor function.
  • Fiber Photometry: This technique was used to measure oxytocin (OXT) release in real-time in the mPFC, allowing researchers to correlate neuronal activity with neuropeptide release.
  • Behavioral Tests: A battery of tests was used to assess anxiety-like behaviors:
  • Elevated Plus Maze (EPM): Measures anxiety by assessing time spent in open versus closed arms.
  • Open Field Test (OFT): Evaluates anxiety by measuring time spent in the center versus periphery of an arena.
  • Fear Conditioning and Extinction: Assesses learning and memory related to fear and the ability to extinguish fear responses.
  • Histology: c-Fos staining was used to identify activated neurons in various brain regions, and co-staining was performed to confirm the co-localization of oxytocin and c-Fos.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • CSD flips the script on sleep's emotional impact: While acute sleep deprivation (aSD) showed transient anxiolytic effects, chronic sleep deprivation (CSD) consistently promoted anxiety-like behaviors and impaired fear memory extinction. This highlights the critical difference between short-term and long-term sleep disruption.
  • PVN oxytocin neurons are central to CSD-induced anxiety: CSD leads to decreased activity in PVN oxytocin neurons, as evidenced by reduced c-Fos expression. This impairment is a key driver of anxiety.
  • Synaptic plasticity is the battlefield: CSD impairs AMPA receptor-mediated synaptic transmission in PVNOXT neurons, reducing their excitability. This suggests that CSD disrupts the fundamental mechanisms of neuronal communication.
  • Targeted stimulation can restore balance: Optogenetic activation of PVNOXT neurons, particularly with high-frequency stimulation (HFS), can reverse CSD-induced anxiety. This suggests that modulating synaptic plasticity in these neurons is a viable therapeutic strategy.
  • Oxytocin release in the mPFC is crucial: The anxiolytic effects of PVNOXT neuron activation are mediated by the release of oxytocin into the medial prefrontal cortex (mPFC), which in turn influences inhibitory neurotransmission in that region.

Key Results

  • CSD increases anxiety: Mice subjected to 7 days of CSD showed increased anxiety-like behaviors in the EPM and OFT, and impaired fear memory extinction.
  • CSD reduces PVN oxytocin neuron activity: c-Fos expression was decreased in oxytocin-positive neurons in the PVN of CSD mice.
  • CSD impairs synaptic transmission: AMPAR-mediated EPSCs in PVNOXT neurons were significantly reduced in CSD mice.
  • Optogenetic activation of PVNOXT neurons is anxiolytic: In normal mice, optogenetic activation of PVNOXT neurons decreased anxiety-like behaviors and improved fear memory extinction.
  • HFS reverses CSD-induced anxiety: HFS of PVNOXT neurons in CSD mice restored normal anxiety levels in the OFT and EPM and improved fear memory extinction.
  • HFS enhances AMPAR function: HFS of PVNOXT neurons in CSD mice led to increased AMPAR-mediated synaptic currents, suggesting a restoration of synaptic plasticity.
  • PVNOXT neuron activation promotes OXT release in mPFC: Optogenetic stimulation of PVNOXT neurons increased oxytocin release in the mPFC, and this release was critical for the anxiolytic effects.
  • CSD reduces mPFC inhibition: CSD led to decreased inhibitory transmission in the mPFC, which was reversed by HFS of PVNOXT neurons.

Limitations and Future Work

  • Peripheral effects: While the study focused on central mechanisms, the authors note that oxytocin neurons also influence the cardiovascular system. They found that CSD-induced cardiovascular responses recovered, but caution that interventions should consider potential peripheral side effects.
  • Mechanisms of synaptic plasticity: The paper proposes that HFS-induced AMPAR potentiation involves Ca2+-dependent signaling cascades and reorganization of the postsynaptic density. Further studies are needed to validate these hypotheses.
  • Therapeutic window: The study suggests intervening in PVNOXT neurons 1 week after CSD to treat anxiety, as cardiovascular responses had recovered by this time. Future work could explore optimal timing and specific stimulation parameters for therapeutic applications.
  • Generalizability: While the study uses mouse models, translating these findings to human anxiety disorders will require further research.

The study provides a compelling mechanistic link between chronic sleep deprivation, PVN oxytocin neuron dysfunction, and anxiety. The findings offer promising avenues for developing novel deep brain stimulation strategies targeting synaptic plasticity for anxiety disorders.

Summary updated

Abstract

Our findings provide key mechanisms and promising deep brain stimulation strategies associated with synaptic plasticity for cSD-induced obsessive anxiety.
BibTeX
@inproceedings{wang2025oxytocin,
  author = {Yuxin Wang and Yifei Zhang and Yanchao Liu and Zhendong Xu and Jiyan Zhang and Like Wang and Yufeng Cang and Xin Jin and Fuyu Han and Zhouhua Li and Chuanwei Hu and Xiangjie Kong and Yuchen Deng and Lu Zhang and Hairong Wang and Haibo Xu and Ming Chen and Linlin Bi},
  title = {{The Oxytocin Neurons in the Paraventricular Nucleus Are Essential for Chronic Sleep Deprivation‐Mediated Anxiety‐Related Behaviors}},
  booktitle = {CNS},
  year = {2025},
  doi = {10.1111/cns.70465},
}
Figure